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The generation of B-cell responses to proteins requires a functional thymus to produce
CD41 T cells which helps in the activation and differentiation of B cells. Because the
mature T-cell repertoire has abundant cells with the helper phenotype, one might predict
that in mature individuals, the generation of B-cell memory would proceed independently
of the thymus. Contrary to that prediction, we show here that the removal of the thymus
after the establishment of the T-cell compartment or sham surgery without removal of the
thymus impairs the affinity maturation of antibodies. Because removal or manipulation of
the thymus did not decrease the frequency of mutation of the Ig variable heavy chain
exons encoding antigen-specific antibodies, we conclude that the thymus controls affinity
maturation of antibodies in the mature individual by facilitating the selection of B cells
with high-affinity antibodies.
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Introduction
B-cell memory confers lasting immunity to microorganisms and
their products by ensuring rapid production of high-affinity
antibodies of switched isotype(s) (particularly immunoglobulin G
(IgG)), distinct from those that predominate in the ‘‘natural’’
immune response. Antibodies opsonize microbes and neutralize
toxins and viruses, precluding cell entry and damage. The high
affinity of recall antibodies may be the most critical property for
effective neutralization of toxins since those are toxic at very low
concentrations. Production of high-affinity class-switched anti-
bodies requires that activated B cells undergo somatic hypermu-
tation and class-switch recombination, followed by antigen
selection of B cells expressing the receptors with enhanced
affinity. B-cell memory is manifested by recall antibody responses
produced by plasma cells generated from memory B cells
upon re-exposure to the antigen and by persisting antigen-
specific antibodies secreted by long-lived plasma cells in the bone
marrow [1].
The generation of B-cell memory requires T cells. Thus,
removal of the thymus in newborn mice (during the first 16 hr of
life) causes severe cellular immunity defects [2] and abolishes
antibody responses to protein antigens [3]. However, removal of
the thymus of mature mice (between 5 and 8 weeks of age) has
no immediate effect on the primary antibody responses to protein
antigens or cellular immune responses [4–6]. Whether or not
removal of the thymus in mature individuals perturbs B-cell
memory is not known.
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T cells promote B-cell responses to protein antigens by directly
interacting with B cells. Thus, deficiencies in CD40 or CD154 or
blocking their interaction by antibodies impairs antibody
responses to protein antigens, immunoglobulin isotype class
switch, somatic hypermutation and B-cell memory [7–9]. Because
primary responses to protein antigens proceed to establish
memory, the specific requirements for the generation and/or
maintenance of B-cell memory cannot be exploited in their
absence. We have recently found that individuals with severe
contraction of the T-cell repertoire owing to the removal of the
thymus and depletion of mature T cells before cardiac trans-
plantation in infancy do not develop hyperimmunoglobulin M
(IgM) syndrome and/or hypogammaglobulinemia, indicating
some level of T-cell help. Preliminary studies in subjects of
cardiac transplantation in infancy suggested defective B-cell
memory to vaccination with protein antigens in spite of normal
primary antibody responses. These observations suggested that
the T-cell help required to generate primary antibody responses
might differ in some respects from T-cell help necessary to
establish and/or evoke B-cell memory responses [10]. Here,
we report that selection of affinity mature antibodies generated
in response to protein antigens requires the integrity of the
thymus.
Results
Thymectomy in mature mice decreases the number of
T cells without contracting TCR diversity
To explore the role of the thymus in B-cell memory responses we
removed the thymus of mice at 5 weeks of age reasoning that at
this age mice already have an established T-cell compartment and
competent cellular immunity [4]. Removal of the thymus at 5
weeks of age completely abrogated recent thymic emigrants
because mice lacking the thymus (in the manuscript referred to as
athymic mice) lacked any measurable T-cell receptor excision
circles (TRECs) at 5 and 10 weeks following thymectomy
(Supporting Information Fig. 1). Consistent with absent thymic
function, athymic mice had reduced CD41, CD251, Foxp31 cells,
at 10 weeks of age (Supporting Information Fig. 3).
Mice from which the thymus had been removed at 5 weeks of
age had fewer T cells in the spleen 5 and 10 weeks after the
surgery, compared with the control mice. Figure 1A and B and
Table 1 show that thymectomy caused a persistent 2.8- or 3.0-
fold decrease in the number of CD41 or CD81 T cells respectively,
10 weeks after surgery. Sham operation of the thymus also
decreased the number of CD41 or CD81 T cells 10 weeks after
surgery, albeit less profoundly than removal of the thymus
(Fig. 1A and B and Table 1). Results from other laboratories are
consistent with ours showing a reduction in the number of CD41
T cells in the spleen following thymectomy. Thus, Gagnerault
et al. [11] found a 2-fold reduction in the number of CD41 T cells
in the spleen following thymectomy in 3-week-old mice; and
Bourgeois et al. [12] found a reduction of almost 2-fold in the
number of peripheral CD41 T cells 15 weeks after interrupting
thymic output in a model of chemical thymectomy.
To determine whether the removal of the thymus caused
compensatory proliferation, we enumerated CD41 or CD81
T cells with a ‘‘memory-like’’ phenotype (CD62L and with high
expression of CD44). Figure 1C and D and Table 1 show that
athymic mice and controls had similar numbers of CD41 or CD81
T cells with a ‘‘memory-like’’ phenotype in the spleen. However,
the proportion of CD41 memory-like T cells was significantly
increased in athymic mice (14%) compared with sham-operated
(11%) or control (9%) mice. Similarly, the proportion of CD81
memory-like T cells was increased in athymic mice (45%) versus
sham-operated (25%) or non-manipulated control mice (19%).
Since the absolute number of memory-like T cells is similar in
athymic and control mice, the increased proportion of memory-
like T cells brought about by the removal of the thymus probably
reflects the decrease in the absolute number of naı¨ve T cells
rather than compensatory proliferation of T cells brought about
by the removal of the thymus. The apparent lack of compensatory
proliferation in athymic mice might partly reflect a decrease in
IL-7, which is produced by thymic epithelial cells [13].
Because cellular immunity depends in part on the diversity of
T-cell receptors we analyzed TCR diversity in athymic mice and in
controls 10 weeks after surgery. We used a novel approach to
quantify TCR b transcript diversity using a real-time polymerase
chain reaction (PCR)-based method [14]. Briefly, the method
Figure 1. Number of lymphocytes in spleens harvested from mice
lacking the thymus, sham-operated or non-manipulated controls at 5
and at 10 weeks of age. Thymectomies were performed 2 days before
the mice turned 5 weeks old. Numbers of lymphocytes were calculated
by multiplying the respective percentage as defined in a flow cytometry
analysis, with specific monoclonal antibodies, by the total number of
white blood cells (WBCs) in athymic (T), sham-operated (S) or
unmanipulated control (C) mice at 5 and 10 weeks (W) after surgery.
The number of (A) CD41 splenocytes and (B) CD81 splenocytes are
shown. (C, D) The number of CD41or CD81 ‘‘memory-like’’ (CD44hi/
CD62L) T cells identified by flow cytometry analysis. Bars represent
the average of each distribution. po0.05, paired two-tailed t-test. Five
mice were analyzed per data point.
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amplifies TCR V beta (b) transcripts using combinations of
primers specific for a total of 240 Vb-Jb combinations. Cycle
threshold (Ct) values were determined for each Vb-Jb combina-
tion for each RNA template and mean Ct values were calculated.
The results shown in Table 2 indicate that Ct values did not
significantly differ in control (17.8), sham-operated (17.9) or
athymic mice (18.7), suggesting that removal of the thymus or
sham operation did not cause significant decrease in TCR diver-
sity or oligoclonal expansions. These results were supported by
Shannon entropy calculated for each Vb-Jb matrix in each set of
mice [15] (Table 2). An estimate of entropy (H) was calculated
by the equation H5S (p log 2p)/log 2(1/240) where p was the
probability of abundance calculated for each Vb-Jb combination
by the equation p5 2y/S2 y, where y was the Ct value for each
Vb-Jb primer pair and p50 when Ct440 cycles. Entropy ranges
from 0 to 1, with 1 representing maximal diversity. Control mice
had average entropy of 0.85, sham-operated mice had an
average entropy of 0.84 and athymic mice had an average
entropy of 0.85. These results agree with values reported for
WT repertoires (0.88 on average) and contrast with values
obtained in SCID-nude mice (0.76) (Dr. Wettstein, personal
communication).
Thymectomy does not impair T-cell memory
To determine whether and how removal of the thymus might
impair memory T-cell responses, we used delayed-type hypersen-
sitivity (DTH) to ovalbumin as an index. Figure 2A shows that
challenge of athymic mice produced greater footpad swelling than
challenge of control mice, indicating that removal of the thymus
did not impair and may instead enhance memory T-cell responses.
To determine whether removal of the thymus impairs primary
T-cell responses and test whether memory T-cell responses are
enhanced in athymic mice, we tested the rate of rejection of male
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Table 2. Cycle threshold values (Ct values) were estimated for all Vb-Jb
combinations for each RNA template and mean Ct values
were calculated. Ninety-five percent confidence intervals (CI)
are showna)
Sample Entropy Mean Ct 95% CI
C-spleen #1 0.85 17.4 17.1–17.4
C-spleen #2 0.84 18.1 17.8–18.4
S-spleen #1 0.83 18.0 17.7–18.4
S-spleen #2 0.84 17.8 17.4–18.2
T-spleen #1 0.84 18.8 18.4–19.1
T-spleen #2 0.85 18.5 18.2–18.8
a) Diversities of expressed Vb-Jb pairs were calculated with Shannon
entropy [15]. An estimate of scaled entropy (H) was calculated for
each Vb-Jb matrix by the equation H5S(p log 2p)/log 2(1/240), where
p was the probability of abundance calculated for each Vb-Jb
combination by the equation p5 2y/S2y, where y was the Ct
value for the Vb-Jb primer pair and p5 0 when Ct440 cycles. Scaled
entropy ranges from zero to one with one representing maximal
diversity. T, athymic mice, S, sham-operated mice, C, non-manipu-
lated mice.
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to female skin grafts. Figure 2B shows that removal of the thymus
slows the kinetics of skin graft rejection in athymic female
recipients to male antigens since the median survival time of male
skin grafts was 37 days in athymic mice and only 25 days in sham-
operated and control mice respectively. This result suggests that
primary T-cell responses were impaired. However, T-cell memory
responses were intact, as second set grafts were rejected with
accelerated kinetics by all recipients, including those lacking the
thymus. The results demonstrated that generation of T-cell
memory does not require an intact thymus.
Removal of the thymus in adult mice increases long-
lived antibody-secreting cells in the bone marrow
Manifest B-cell memory requires antigen-specific antibody produc-
tion at times remote from primary antigen stimulation. At least
some B cells engaged in a primary response must survive and some
must have the ability to respond upon re-exposure. These antibody
responses require T-cell help [16]. Whether the thymus is
necessary to generate B-cell memory responses beyond generating
a diverse T-cell repertoire is not known. To answer that question
we tested B-cell memory in mice from which the thymus had been
removed or manipulated without removal 5 weeks before.
To exclude the possibility that thymectomy imposed a B-cell
autonomous defect independent of T cells we asked whether
athymic mice mounted antibody responses to NP-Ficoll, a
T-independent antigen. Figure 3A and B shows comparable
concentrations of NP-specific IgM and IgG3 21 days following
immunization in athymic mice (230mg/mL IgM and 64 mg/mL
IgG3, on average) and sham-operated mice (167 mg/mL IgM and
86 mg/mL IgG3, on average). Hence, thymectomy did not perturb
T-cell-independent antibody production. Indeed, B cells devel-
oped normally in mice lacking the thymus compared with sham-
operated mice. Supporting Information Fig. 2 shows that the
average number of mature CD191 B cells is comparable in mice
lacking the thymus, sham-operated or control mice at 5 weeks
and at 10 weeks of age respectively. There were no population
imbalances, as the number of marginal zone B cells (CD191 and
CD211) or follicular (CD191, CD211 and CD231) B cells was
comparable in athymic, sham-operated and control mice.
A hallmark of B-cell memory is the rapid production of high-
affinity antibodies upon re-exposure [16]. These properties
reflect the survival of fully differentiated antigen-specific B cells
and plasma cells. To determine whether B-cell memory responses
were impaired in mature athymic mice, we studied responses to
immunization with 4-hydroxy-3-nitrophenyl acetyl (NP) conju-
gated to ovalbumin. Figure 4A and B shows that athymic mice
produced as much NP-specific IgM or IgG1 as sham-operated
mice, indicating that removal of the thymus did not impair
antigen-specific primary or secondary antibody responses to
vaccination with proteins. Consistent with that conclusion we
found that the number of antibody-secreting cells (ASCs) present
in the bone marrow 6 months after immunization was main-
tained in sham-operated mice and increased by 2-fold in athymic
Figure 2. Primary cellular immune responses are delayed in mice
lacking the thymus but T-cell memory responses are maintained.
(A) DTH responses in control (C), sham-operated (S) or athymic (T) mice
to intradermic injection of 20mg ovalbumin were examined in the
footpad of mice 6 days after priming by subcutaneous injection with 100mg
of ovalbumin (priming) or PBS (control). Footpad swelling measured in
millimeters is indicated on the y-axis. Data are shown as mean7SEM
of n5 5. po0.05, paired two-tailed t-test. (B) Kaplan–Meier survival
curves for H-Y incompatible skin grafts in athymic (T), sham-operated
(S) or control (C) mice. Grafts were considered rejected when 90% or
more of the graft lacked any viable signs in the hair, pigment and scale
pattern. The median survival time of first set grafts was 25 days in
control mice, 25 days in sham-operated mice and 37 days in mice
lacking the thymus. Skin graft rejection by athymic mice was
significantly delayed compared to rejection in controls (p5 0.0052,
log-rank, Mantel–Cox test). Secondary transplants were done 8–12
weeks after rejection of the first transplant. The median survival time
of initial transplants was 15 days in control mice, 16 days in sham-
operated mice and 19 days in athymic mice. The results reflect
transplants done in five mice of each group.
Figure 3. T-independent antibody responses maintained in athymic
mice. T-independent antibody responses to NP-Ficoll in athymic mice
(T) or in sham-operated (S) mice. The concentrations of (A) NP-specific
IgM or (B) NP-specific IgG3 prior to and 21 days after immunization are
shown. Mice lacking the thymus and sham-operated mice had on
average 4.0 and 5.0 mg/mL NP-specific IgM respectively, and non-
detectable NP-specific IgG3, prior to immunization. Athymic and
sham-operated mice had 230 and 167 mg/mL NP-specific IgM, respec-
tively. on average, 21 days after immunization, Mice lacking the
thymus and sham-operated mice had on average 64 and 86mg/mL NP-
specific IgG3, 21 days after immunization, respectively. The concentra-
tions of NP-specific IgM or IgG3 in athymic mice and in sham-operated
mice did not significantly differ. Data reflect mean7SE, n5 6.
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mice compared with non-manipulated controls (Fig. 5). In fact,
since the number of ASCs in athymic mice was significantly
increased compared with the number of ASCs in control or sham-
operated mice, our results suggest that the thymus in the adult
may inhibit either the differentiation or the maintenance of long-
lived ASCs in the bone marrow.
Removal or manipulation of the thymus impairs
affinity maturation of antibodies
The most significant function associated with antibody recall
responses is the selection of cells bearing receptors with increased
affinity for the antigen. To determine whether affinity maturation
requires the integrity of the thymus in the adult, we sampled
antibody heavy chain variable region nucleotide and protein
sequences of IgG1-positive B cells obtained from mice that had
their thymus removed, manipulated (sham operation) or of non-
manipulated controls, 10 days following booster immunization.
Sequences were obtained from cloned PCR gene products
amplified with VH186.2-specific primers (NP selects antibodies
encoding the VH186.2 canonical germline sequence rearranged to
DFL16.1 and JH2 [17]) and Cg1 reverse primers in a nested PCR
reaction and with Pfu proof-reading polymerase. Two sequences
were obtained per clone and a consensus was generated. To
determine whether selection of antigen responsive B cells was
perturbed in athymic or sham-operated mice, we first determined
the frequency of the VH186.2, DFL16.1 and JH2 joins in all the
unique VH186.2 encoding HC sequences obtained for each group
of mice. Out of 76 sequences encoding VH186.2 exons obtained
from athymic mice, 19 had different joins (25%) and 12 used
DFL16.1 and JH2 (63%). In a total of 70 sequences encoding
VH186.2 exons obtained from sham-operated mice, 37 had
different joins (53%) and 20 used DFL16.1 and JH2 (54%). In
48 sequences encoding VH186.2 exons obtained from control
mice, we found 17 different joins (35%) and 11 used DFL16.1 and
JH2 (65%). These results suggested that removal of the thymus
decreased, while sham operation increased, the clonal diversity of
NP-responding B cells in comparison with controls even though the
majority of clones encoding the VH186.2 gene segment also
encoded DFL16.1 and JH2 in all the three groups of mice.
Next, we compared the amino acid sequences of CDR3 regions
encoded by each unique join. NP-binding antibodies often encode
Tyr or Gly at position 95 [18]. While 94% CDR3 joins sequenced
from control mice had Y or G at position 95, only 68% of the unique
CDR3 joins obtained from sham-operated mice had Y or G at
position 95 and 84% of the unique CDR3 joins sequenced from
athymic mice had Y or G at position 95. These results suggest that
removal of the thymus and sham operation disturbs selection of
NP-reactive clones. These results are consistent with defective selec-
tion of NP-specific antibodies in sham-operated and athymic mice.
Because defective selection of NP-specific antibodies could
result from defective somatic hypermutation, we measured the
mutation frequency of the unique VH gene segments obtained
from athymic, sham-operated or control mice in relation to the
VH186.2 germline sequence. The VH mutation frequencies were
2.6, 3 and 2.3% in athymic, sham-operated and control mice
respectively, suggesting that manipulation or removal of the
thymus in the adult did not impair somatic hypermutation per se.
However, the frequency of mutation in the CDR1 region of
VH186.2 encoding antibodies obtained from control mice was
13.6% and consisted of very focused changes at mostly three
positions (Fig. 6A), but the frequency of mutation in the CDR1
region of antibodies obtained from athymic and sham-operated
mice was only 8.5 and 7.2% respectively, and less focused
(Fig. 6B and C). Decreased frequencies of mutations in the CDR1
regions of the VH186.2 exons in athymic or sham-operated mice
compared with CDR1 sequences obtained from non-manipulated
mice suggested a defect in the selection of antigen-specific anti-
bodies. In fact, the fraction of sequences containing the W33L
Figure 5. Number of NP-specific IgG1 antibody-secreting cells (ASCs) in
the bone marrow of mice lacking the thymus or control mice, 6 months
after boost immunization. Mice lacking the thymus (T) had on average
198 ASCs per 106 B cells while sham-operated mice (S) had an average
of 113 ASCs per 106 B cells and, control mice (C) had an average of 100
ASCs per 106 B cells NP-specific IgG1 antibody-secreting cells in the
bone marrow. Data are shown as mean7SEM of n5 4 mice per group.
The number of ASCs in athymic mice was significantly increased
compared with the number of ASCs in control (p5 0.0042) or sham-
operated mice (p5 0.0075) (unpaired two-tailed t test).
Figure 4. Removal of the thymus or sham operation maintained
IgG1-specific antibody responses. (A, B) T-dependent responses to NP-
ovalbumin. The concentrations of NP-specific IgM or NP-specific IgG1
prior to (PI) and 21 days after primary (D21) or booster immunization
(21PB) respectively are shown. (A) Athymic mice (T) and sham-
operated mice (S) had an average of 8.4 and 4.4 mg/mL NP-specific
IgM, prior to immunization (PI), 76 and 111mg/mL, 21 days after
immunization (D21), 293 and 296 mg/mL 21 days after boosting (21PB)
respectively. (B) Mice lacking the thymus or sham-operated mice had
no detectable NP-specific IgG1 prior to immunization, but produced on
average 121 and 231mg/mL NP-specific IgG1 21 days after immuniza-
tion, 596 and 622 mg/mL 21 days after boosting respectively. Data reflect
mean7SE, n5 6 mice per group. Paired two-tailed t-test analysis
revealed no significant differences between athymic and sham-
operated mice.
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A CDR1 CDR2
CDR1 CDR2
CDR1 CDR2
B
C
Figure 6. VH CDR1 and CDR2 DNA sequences of IgG1-B cells from mice lacking the thymus (T) sham-operated (S) or control (C) mice. Sequences
were obtained from the spleens of mice 10 days following boost immunization. Shown are the CDR1 or CDR2 sequences of all the distinct VH
sequences aligned to the germline VH186.2 segments. CDR1 and CDR2 regions are shadowed. (A) Sequences obtained from control mice,
(B) sequences obtained from athymic mice, and (C) sequences obtained from sham-operated mice are shown.
Eur. J. Immunol. 2012. 42: 500–510 Molecular immunology 505
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NP-affinity enhancing mutation was decreased in athymic mice
(87%, Fig. 7A) and in sham-operated mice (21%, Fig. 7B),
compared with that fraction (98%) in sequences obtained from the
control mice in which all sequences except for one contained the
W33L mutation (Fig. 6C). Contingency analysis (w2 test) revealed
the reduction in the number of W33L mutations in athymic or
Figure 7. VH aminoacid sequences of IgG1-B cells. The aligned translation of all the distinct VH186.2 segments obtained from (A) mice lacking the
thymus, (B) sham-operated mice and (C) control mice are shown. CDR1 and CDR2 regions are shadowed, and residue 33 is indicated in a darker
grey shade.
Eur. J. Immunol. 2012. 42: 500–510Mouhammed AbuAttieh et al.506
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sham-operated mice relative to control mice to be significant
(po0.05, po0.0001 respectively). Remarkably, manipulation of
the thymus caused a significant reduction in the number of the
W33L mutations compared with that number in athymic mice
(po0.0001), suggesting that manipulation of the thymus without
its removal compromises affinity maturation more seriously than
its removal. Because the W33L mutation in the VH186.2 exon by
itself causes a 10-fold increase on affinity to NP [19], the reduction
in the frequency of the W33L mutation in athymic and in sham-
operated mice indicates that the integrity of the thymus is neces-
sary for the production of high-affinity antibodies.
Discussion
Our results show that the thymus contributes to priming T-cell
responses (as expected), and to affinity maturation of antibodies.
Surprisingly, in spite of compromised selection of B cells bearing
high-affinity B-cell receptors, production of long-lived ASCs is not
defective in athymic or sham-operated mice. In fact, our results
suggest the possibility that the thymus may inhibit the generation
and/or maintenance of long-lived ASCs. Since removal of the
thymus did not critically contract the T-cell receptor diversity or
decrease the number of T cells in a substantive manner, these
results suggest that affinity maturation of antibodies is critically
dependent on the integrity of the thymus.
Recent studies support the idea that T-cell help and the B-cell
receptor (BCR) strength determine B-cell fate in response to
T-dependent antigen activation. Thus, Paus et al. [20] and Phan
et al. [21] suggested that high BCR affinity for antigen dictates
differentiation to extra-follicular ASCs, causing primary antibody
responses. O’Connor et al. [22] proposed that B cells with a low-
affinity BCR typically undergo somatic hypermutation, while
B cells with BCRs of moderate affinity for antigen produced
mostly long-lived ASCs. BCR affinity and T-cell help are inter-
dependent since B cells present antigens to T cells following
Ig-dependent internalization [23]. Thus, B cells that have a
competitive advantage to bind antigen owing to higher affinity
receptors may also better compete for limiting T-cell ‘‘help,’’
which in turn may determine their fate. The interdependence
between BCR affinity and B-cell antigen presentation to T cells
has made it difficult to dissociate the contributions of each to
B-cell selection and differentiation. In a ‘‘tour de force’’, Victora
et al. [24] showed that enhancing antigen B-cell presentation
without engaging the BCR promoted migration of B cells from the
light zone to the dark zone of the germinal center, clonal
expansion and plasmablast differentiation. These authors
concluded that T-cell help limits expansion and differentiation of
B cells in the germinal center independently of BCR engagement.
However, enhancing B-cell antigen presentation by germinal
center B cells did not induce antibody affinity maturation,
suggesting that the combined signals provided by BCR ligation
and engagement of T cells determine the B-cell fate.
Our results showing normal or enhanced antibody responses
to protein antigens suggested that T-cell help in athymic or sham-
operated mice is adequate to activate and promote differentiation
of ASCs short- and long-term. However, since removal or
manipulation of the thymus compromised affinity maturation of
antibodies, our results suggest that disruption of thymic integrity
selectively impairs affinity maturation of antibodies in much the
same way as enhancing antigen presentation independently of
the BCR as reported by Victora et al. [24]. Because removal of the
thymus interrupts the flux of new T cells we considered the
possibility that the availability of cognate help may be reduced to
a greater extent than non-cognate help, enhancing BCR-inde-
pendent antigen presentation, which in turn would impair
selection of high-affinity B cells. We propose that absence of
optimal cognate T-cell help owing to interruption of thymic
emigration or following manipulation of the thymus abrogates
competition for B cells expressing B-cell receptors with high
affinity for antigen randomizing differentiation and apoptosis.
Other functions of the thymus such as production of IL-7 or
production of regulatory T cells could also contribute to the
regulation of immunity. We observed that removal of the thymus
impairs production or maintenance of T regulatory cells
(Supporting Information Fig. 3). Whether or not decreased
production of T regulatory cells in athymic mice contributes to
defective affinity maturation of antibodies in these mice is not
known and this question will be an interesting one to resolve.
Our findings concur with those of Ahuja et al. [25] who
proposed that the long-lived ASC compartment is maintained
independently of the memory B-cell compartment because it does
not decline when memory B cells are abrogated. Our results
indicate that differentiation of long-lived ASCs occurs indepen-
dently of affinity maturation that normally accompanies B-cell
memory responses. Our work suggests that strategies to immu-
nize individuals with congenital or acquired thymic defects (such
as following cardiac transplantation or cardiac surgery in
infancy), or with contracted T-cell repertoires (such as in aging or
after T-cell depletion to treat cancer) would benefit from new
vaccine designs including surrogates of cognate T-cell help.
Materials and methods
Thymectomy
Thymuses were removed surgically from mice or sham-surgery was
performed at 5 weeks of age. Mice were anesthetized with ketamine
(120–200 mg/kg) 1 xylazine (10 mg/kg) ip. An incision was made
on the ventral neck midline extending from 0.5 cm cranial of the
sternal notch. The clavicle was cut along the sternum to the second
rib and retracted to expose the trachea, sternohyoid and sternothyr-
oid muscles, which were gently separated to expose the superior
end of the thymic lobes. The thymus was then gently dissected with
blunt instruments and excised by vacuum. The thorax was closed
using 6–0 absorbable suture placed through the dorsal thorax to
draw the clavicle and ribs together. The fat pad with the
submaxillary gland was returned to its original position and held
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in place by liquid skin adhesive. Skin was closed using 6–0
absorbable suture. Mice were monitored every 12 h for the first 48 h,
and daily thereafter. Sham-operated mice underwent the same
surgical procedure, except for the fact that the thymus was not
excised, just manipulated with the tip of blunt scissors.
Blood collection
This was done following the recommendations of the University
of Michigan Committee on Use and Care of Animals (UCUCA).
Immunizations
T-independent immunizations were performed as explained by
Mantchev et al. [26] by injecting mice ip with 30 mg of NP-Ficoll
(NP41- AECM-Ficoll; Biosearch Technologies, Novato, CA, USA)
diluted in 100mL PBS once. Primary T-dependent immunizations
were performed by ip injection of 100mL of an emulsion of
incomplete Freund’s adjuvant containing 100 mg NP(25)-ovalbu-
min (Biosearch Technologies) and boost immunizations
performed by ip injection of 100mL of a PBS solution containing
10 mg NP(25)-ovalbumin. To obtain RNA from memory B cells,
mice were boosted a second time by iv injection of 50 mg NP(25)-
ovalbumin dissolved in 100mL of PBS.
Strains of mice
C57BL/6 mice were purchased from The Jackson Laboratory (Bar
Harbor, ME, USA). Mice were housed in a specific pathogen-free
facility at the University of Michigan. All mice were between 5
and 25 weeks of age and all experiments were carried out in
accordance with protocols approved by UCUCA.
Ig gene analysis
RNA was obtained from spleen cells and extracted with QIAGEN
RNeasy (Qiagen, Valencia, CA, USA). cDNA was obtained from
0.2mg of RNA using oligo(dT) primed reverse transcription.
VH186.2 gene sequences joined to the IgG1 constant region were
amplified with VH186.2- and Cg1-specific primers in a nested
reaction and with Pfu polymerase, followed by cloning with pCR4-
TOPO (Invitrogen, Carlsbad, CA, USA). Sequencing of cloned PCR
fragments was done by the Mayo Clinic Sequencing Core. Forward
primer: CATGCTCTTCTTGGCAGCAACAGC (specific for VH186.2),
reverse primer: GTGCACACCGCTGGACAGGGATCC (specific for
Cg1). PCR was performed for 30 cycles of 1 min at 941C, 2 min at
551C and 3 min at 721C. Nested PCR amplification forward primer:
CAGGTCCAACTGCAGCAG, and reverse primer, AGTTTGGGCAG-
CAGA. Sequences were aligned and analyzed using Sequencher
software (Gene Codes, MI, USA) and with a software program
developed by Dr. Cavalcoli at the University of Michigan
Sequencing Core. VH, D and JH gene CDR3 sequence assignments
were done according to the international ImMunoGeneTics
(IMGT) system software developed by Dr. Lefrank at the CNRS,
France [27]. Complementary determining regions were deter-
mined according to Kabat et al. [28].
FACS analysis and antibodies
Splenocytes were obtained and prepared for flow cytometry
analysis as in [29]. Fluorescently conjugated or biotinylated
antibodies were purchased from BD Biosciences unless noted: rat
anti-mouse CD4 (GK 1.5), rat anti-mouse CD21a/CD35 (7G6),
rat anti-mouse CD3e (145-2C11), rat anti-mouse IgDb (AMS9.1),
rat anti-mouse CD4 (GK1.5), rat anti-mouse CD44 (Pgp-1,
Ly-24), rat anti-mouse CD23 (Fc e RII), rat anti-mouse IgMb
(DS-1), rat anti-mouse CD8a (Ly-2), rat anti-mouse CD19 (1D3),
rat anti-mouse CD62L (LECAM-1, Ly22), rat anti-mouse CD25
(IL-2R a chain, p55) and rat anti-mouse Foxp3 (FJK-16S,
eBiosciences). Biotynilated antibodies (Abs) were revealed by
streptavidin-PE-Cy5 purchased from BD Biosciences, USA. Data
were collected on a FACScalibur (BD Biosciences) and analyzed
with CellQuest software (BD Biosciences). Isotype controls were
used to define gates.
DTH assay
Mice were primed by subcutaneous injection of 100 mg of
ovalbumin dissolved in PBS, and challenged by intra-dermal
injection of 20 mg of ovalbumin in PBS in the footpad, 6 days after
priming. Non-primed mice challenged with PBS were included as
controls. Footpad swelling was measured with a caliper.
Effective swelling indicates the difference in the thickness of
footpads in the same mice (one injected with the antigen, another
injected with PBS). Responses were recorded at 24 and 48 h
post-challenge.
Skin grafts
Skin grafts were performed according to a modified technique of
Billingham et al. [30]. Secondary transplants were 30 days after
the primary graft was shed.
TRECS
DNA was obtained from splenocytes with a DNeasy Blood and
Tissue Kit (Qiagen). PCR amplification of sjTREC DNA was done
from 100 ng of DNA in a Mastercycler ep realplex real-time PCR
system (Eppendorf) using specific primers targeting murine dRec-
cJa excision circles. Real-time PCR cycler conditions were set for
951C for 10 min, followed by 40 cycles of 951C for 15 sec and
601C for 1 min with 5mM forward and reverse primers and
0.05mL of 100mM FAM-QSY probe. Forward primer (upstream of
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cJa segment): 50-CAT TGC CTT TGA ACC AAG CTG-30; Reverse
primer (downstream of the dRec1 segment): 50-TTA TGC ACA
GGG TGC AGG TG-30 according to [31]. A fluorescent probe for
RT-PCR: FAM-CAG GGC AGG TTT TTG TAA AGG TGC TCA CTT-
QSY (Applied Biosystems). The mouse transferring receptor gene
Tfrc gene (TaqMan Copy Number Reference Assay, Applied
Biosystems) was amplified to quantify cell number in mouse DNA
samples. Each sample was run in triplicate. Standard curves were
created with either serial dilutions of sjTREC plasmid DNA or of
C57BL/6J DNA followed by Tfrc gene amplification.
Statistical analysis
Performed using Prism software (Prism Software, Irvine, CA,
USA). Group comparisons were performed using the unpaired,
two-sided Student’s t-test after testing the global difference with a
one-way analysis of variance (ANOVA). Comparison of skin graft
survival was performed by a log rank test. A value of po0.05 was
considered significant.
ELISA
MaxiSorp-treated or PolySorp-treated polystyrene 96-well plates
(Thermo Scientific, Rochester, NY, USA) were coated with 4mg/mL
of goat anti-mouse Ig (SouthernBiotech, Birmingham, AL, USA) in
PBS to measure total Ig, or with 5mg/mL of NP-BSA in borate saline
buffer to detect NP-specific antibodies, for 1 h at room temperature.
ELISA was performed according to previously described protocols
[29, 32]. Plates were developed with ABST (SouthernBiotech) read
at 405 nm in microplate reader Synergy 2 (BioTec Laboratories,
Suffolk, UK) and analyzed using Gen 5 software version 1.04.5
(BioTek, VT, USA). The 17.2.25 IgGl was used as a standard for
quantification.
ELISPOT
ELISPOT was done according to standard procedures in the
laboratory [26]. MultiScreen HTS-HA 96-well plates (Millipore,
Billerica, MA, USA) were coated with 5mg/mL NP-BSA or 5mg/mL
BSA in sodium carbonate buffer overnight at 41C and blocked with
5% milk in TBS-Tween for 2 h at 371C. B cells isolated from the
spleen by negative selection were serially diluted, seeded in the
wells and cultured in complete RPMI-1640, overnight at 371C in
5% CO2 atmosphere. ELISPOT analyses of ASCs obtained from
adoptively transferred recipients were done with splenocytes. To
detect NP-specific ASCs, each well was washed and incubated with
AP-conjugated goat anti-mouse IgM or IgG antibody (South-
ernBiotech) for 2 h at 371C. Each well was developed with BCIP/
NBT (Sigma-Aldrich, St. Louis, MO, USA). The number of spots of
NP-specific IgM- or IgG-secreting cells was counted by Immuno-
Spot Professional Analyzer version 5.0.9 (Cellular Technology,
Shaker Heights, OH, USA) and confirmed by direct observation.
TCR b chain diversity analysis
TCR b chain diversity analysis was done as reported [14]. Briefly,
RNA was obtained from spleens using a RNeasy Protect Minikit
(Qiagen). Residual DNA was removed from RNA samples using
an RNase-Free DNase Set (Qiagen). cDNA was produced from
15 ng of RNA with a 20 pmol of a 50biotynilated TCR Cbbb primer
and pools of 21 different TCR Vb primers homologous to the
CDR1 region providing 66 pmol of each (three pools of five and
one pool of six primers), at 501C for 32 min followed by
incubation at 941C to inactivate the reverse transcriptase. cDNA
synthesis was followed by PCR amplification at 1 min at 941C,
30 sec at 601C and 1 min at 721C for 25 cycles. RT-PCR products
were purified by QIAquick PCR Purification Kit (Qiagen) and
biotynilated products separated with MyOne
TM
Streptavidin C1
Dynabeads (Dynal Biotech ASA, Oslo, Norway) according to the
manufacturer’s instructions. TCR Vb diversity was determined by
real-time PCR in a total of 240 individual reactions using
combinations of 20 TCR Vb and 20 TCR Jb primers, as described
[14]. Reactions were performed in a 10 mL volume containing
10 pmol of a nested TCR Vb primer homologous to TCR Vb CDR2,
10 pmol of a TCR Jb primer, l mL of purified PCR products and
5mL of Power SYBR Green PCR master mix (2 ) (Applied
Biosystems). Cycling was preceded by incubation at 501C for
2 min and at 951C for 10 min, followed by 40 cycles of 15 sec at
951C and 1 min at 601C. Data were analyzed with the 7900HT
Sequence Detection System Version 2.3 software (Applied
Biosystems) to estimate the cycle threshold (Ct) for all reactions.
Ct values are fractional cycle numbers at which fluorescence
passes the threshold set to be within the exponential region of the
amplification curve corresponding to a linear relationship
between the log of change in fluorescence and cycle number.
Primers were as published [14] and synthesized by Invitrogen.
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